The average American cancer patients lives about two years longer than their opposite number in Europe, says a news report issued by Health Affairs. The authors explain that the higher US costs in cancer therapies appear to have paid off, compared to medical treatments and cancer survival outcomes in Europe. Tomas Philipson, from the University of Chicago, and team examined cancer care costs and outcomes in the USA and ten European nations from 1983 to 1999...
More...
More...